Infants with very high risk KMT2A B-ALL

Clinical trials for Infants with very high risk KMT2A B-ALL explained in plain language.

Never miss a new study

Get alerted when new Infants with very high risk KMT2A B-ALL trials appear

Sign up with your email to follow new studies for Infants with very high risk KMT2A B-ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Engineered immune cells take on childhood leukemia in new trial

Disease control Recruiting now

This phase 2 trial is testing a personalized cell therapy called CART19 in children and young adults with certain high-risk forms of B-cell acute lymphoblastic leukemia (B-ALL). The therapy uses the patient's own immune cells, which are modified in a lab to recognize and attack c…

Matched conditions: INFANTS WITH VERY HIGH RISK KMT2A B-ALL

Phase 2 • Sponsor: Stephan Grupp MD PhD • Aim: Disease control

Last updated Jun 27, 2026 09:11 UTC

Infants with very high risk KMT2A B-ALL

Get alerted when new Infants with very high risk KMT2A B-ALL trials appear

Engineered immune cells take on childhood leukemia in new trial